Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 21 of 21 publications.

Rao S, McQuay LJ, Forns J, MacKay R, Danysh HE, Doshi D, Abler V, Anthony MS, Layton JB. Evaluation of mortality in users of pimavanserin compared with other atypical antipsychotics in patients with Parkinson's disease psychosis: an update. Drug Saf. 2025 Apr 9. doi: 10.1007/s40264-025-01543-8

Rao S, McQuay L, Forns J, MacKay R, Aquilina T, Doshi D, Abler V, Anthony MS, Layton B. Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics. Poster presented at the 2024 Parkinson Study Group (PSG) 33rd Annual Meeting; December 5, 2024. Nashville, TN. Previously presented at the Neuroscience Education Institute (NEI) Congress 2024.

Rao S, Forns J, Danysh HE, Calingaert B, Dempsey C, Aquilina T, Pathak S, Anthony MS, Layton JB. Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States. J Alzheimers Dis. 2024 Dec;102(4):1260-70. doi: 10.1177/13872877241297361

Rao S, McQuay L, Forns J, MacKay R, Aquilina T, Doshi D, Abler V, Anthony MS, Layton B. Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics. Poster presented at the Neuroscience Education Institute (NEI) Congress 2024; November 8, 2024. Colorado Springs, CO.

Rao S, McQuay L, Forns J, MacKay R, Aquilina T, Doshi D, Abler V, Anthony MS, Layton B. Comparing the mortality risk of patients on FDA-approved treatment for Parkinson's disease psychosis, pimavanserin, vs other antipsychotics. Poster presented at the 37th Annual Psych Congress; October 29, 2024. Boston, MA. Previously presented at the Neuroscience Education Institute (NEI) Congress 2024.

Mayer SE, Kawai A, Fuller CC, Agan AA, Rao S, Koram N, Calingaert B, Marshall J, Connolly JG, Moyneur E, Jamal-allial A, Brown J, Burk J, Chomistek A, Daniels K, Dea K, DeFor TA, Diessner B, Djibo DA, Ezzy S, Hawrusik R, Johannes CB, Kendrick K, Layton JB, Ma Q, Mai X, Mack M, Pawloski PA, Reynolds JS, Selvan M, Sharma V, Vetter J, McMahill-Walraven CN, Platt R, Gilsenan A. Interim utilization results from a post-approval safety study of Pfizer-BioNTech monovalent COVID-19 vaccine in the United States. Poster presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.

Rao S, Forns J, Danysh HE, Calingaert B, Dempsey C, Aquilina T, Pathak S, Anthony MS, Layton JB. Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis in the United States. Presented at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2024; March 5, 2024. Lisbon, Portugal.

Mitrani-Gold FS, Raychaudhuri A, Rao S. Systematic review and meta-analysis to estimate the antibacterial treatment effect of nitrofurantoin for a non-inferiority trial in uncomplicated urinary tract infection. J Glob Antimicrob Resist. 2020 Sep;22:68-77. doi: 10.1016/j.jgar.2020.01.027

Rao S, Kshirsagar AV, Brookhart MA, Keil A, Loehr L, Jonsson-Funk M, Poole C. Development and validation of a prediction model for 1-year risk of thromboembolism in hemodialysis patients with atrial fibrillation. Poster presented at the Virtual 2020 36th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2020.

Davidson JE, Fu Q, Ji B, Rao S, Roth D, Magder LS, Petri M. Renal remission status and longterm renal survival in patients with lupus nephritis: a retrospective cohort analysis. J Rheumatol. 2018 May 28;45(5):671-7. doi: 10.3899/jrheum.161554

Davidson JE, Fu Q, Rao S, Magder LS, Petri M. Quantifying the burden of steroid-related damage in SLE in the hopkins lupus cohort. Lupus Sci Med. 2018 May 14;5(1):e000237. doi: 10.1136/lupus-2017-000237

Rao S, Kshirsagar AV, Layton JB, Brookhart MA. Anticoagulation treatment and management in hemodialysis patients with atrial fibrillation. Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(S2):593.

Davidson J, Fu Q, Ji B, Rao S, Roth D, Magder LS, Petri M. The long-term clinical outcomes of lupus nephritis. Poster presented at the 2016 ACR/ARHP Annual Meeting; November 11, 2016. Washington, DC. [abstract] Arthritis Rheumatol. 2016 Oct; 68(suppl 10). doi: 10.1002/art.39977

Rao S, Li X, Brookhart A. Use of copay as an instrumental variable for adherence in comparative safety and effectiveness research. Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(S3).

Patel V, Lin F-J, Ojo O, Rao S, Yu S, Zhan L, Touchette DR. Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention. Pharm Pract (Granada). 2014 Jul;12(3):438. doi: 10.4321/s1886-36552014000300007.

Oglesby A, Korves C, Laliberte F, Dennis G, Rao S, Suthoff ED, Wei R, Duh MS. Impact of early versus late systemic lupus erythematosus (SLE), diagnosis of clinical and economic outcomes. Appl Health Econ Health Policy. 2014 Apr;12(2):179-90. doi: 10.1007/s40258-014-0085-x

Walker DR, Ivanova J, Betts KA, Rao S, Wu EQ. Association of patient characteristics with the initiation of dabigatran versus warfarin among anticoagulant naive patients with non-valvular atrial fibrillation. Poster presented at the QCAR 2013 Annual Meeting; May 15, 2013. Baltimore, MD. [abstract] Circ Cardiovasc Qual Outcomes. 2013 May; 6(Suppl_1):A211. doi: 10.1161/circoutcomes.6.suppl_1.A211

Touchette DR, Rao S, Dhru PK, Zhao W, Choi Y-K, Bhandari I, Stettin GD. Identification of and intervention to address therapeutic gaps in care. Am J Manag Care. 2012 Oct 1;18(10):E364-371.

Ivanova J, Birnbaum H, Desai U, Kirson N, Cummings A, San Roman A, Rao S, Andrews R, Doan Q, Zachry W. Prevalence, comorbidity burden and treatment of Alzheimer's disease among the elderly in the United States. Poster presented at the Alzheimer's Association International Conference 2012; July 14, 2012. Vancouver, Canada. [abstract] Alzheimers Dement. 2012 Jul 1; 9(4S_Part_16):P575-608. doi: 10.1016/j.jalz.2012.05.2074

Rao S, Lin FJ, Ojo O, Patel V, Yu S, Zhan L, Touchette DR. A decision modeling approach to evaluate the cost-effectiveness of prasugrel vs. clopidogrel in patients with planned percutaneous coronary intervention. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 21, 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):a39-40.

Rao S, Amatya A, Patel P. Predictors of computed tomography scan use in patients with coronary artery disease (CAD) in emergency departments in the United States. Poster presented at the 2012 ISPOR 15th Annual European Congress; May 15, 2010. Atlanta, GA. [abstract] Value Health. 2010 May; 13(3):a174-5. doi: 10.1016/S1098-3015(10)72849-7